Resident in Clinical Pathology
Mass General Hospital
Disclosure(s): Day Zero Diagnostics: Advisor/Consultant, Ownership Interest
Melis Anahtar, MD, PhD is currently a Clinical Pathology resident as Massachusetts General Hospital (MGH) in Boston, MA. She completed her fellowship in Medical Microbiology at MGH last June, and previously obtained her MD/PhD from Harvard Medical School and MSc in Immunology from Oxford University on a Rhodes Scholarship. She is a co-founder of Day Zero Diagnostics, a genomics-based start-up that is developing a rapid and comprehensive sequencing-based assay for sepsis. Her research interests include host-microbe interactions, antimicrobial resistance, and novel diagnostics.